Covington Advises Getinge on its $477M Acquisition of Paragonix Technologies

Covington Advises Getinge on its $477M Acquisition of Paragonix Technologies

August 23, 2024

NEW YORK-Covington represented Getinge in its agreement to acquire Paragonix Technologies, Inc., a leading organ transport products and services company in the United States, for an aggregate purchase price, including upfront and earn out payments, estimated to be approximately $477 million.

Getinge provides hospitals and life science institutions with products and solutions aiming to improve clinical results and optimize workflows. Founded in 2010, Paragonix Technologies is a privately held company headquartered in Waltham, Massachusetts. With the acquisition of Paragonix Technologies - a pioneer and innovator in organ transport and preservation - Getinge marks its entry into a rapidly advancing field driven by rising transplant volumes, technological innovations and evolving clinical practices.

The Covington team was led by Jack Bodner, with assistance from Alicia Zhang, James DeFillippo, and Matthew Gragtmans (M&A); Jenna Wallace, Nori Lu, Michelle Barineau, and Montene Speight (Employment); Van Ellis, Jeremy Hutcher, and Jeff Tsai (Life Sciences Commercial); Ansgar Simon and Michael Chittenden (Tax); Sina Utku and Marie Lavalleye (Intellectual Property); Pamela Forrest, Christina Kuhn and Sarah Cowlishaw (FDA Regulatory and EU Regulatory); Sarah Franklin andJulia Post (Healthcare Compliance); and James Dean, Stacy Kobrick, Silvia Wu, and Sibel Yilmaz (Antitrust).